Journals / Türk Kardiyoloji Derneği Arşivi / 2003 / Cilt: 31 - Sayı: 1

Relationship between silent myocardial ischemia and aortic valve sclerosis in patients with essantial hypertansion

Esansiyel hipertansiyonlu hastalarda sessiz miyokard iskemisi ile aort kapak sklerozu arasındaki ilişki

Pages
29–34
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Silent ischemia was significantly correlated with the presence of aortic valve sclerosis (r=0.27, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Silent myocardial ischemia has been observed in hypertensive patients with a prevalence of 35-45%.
📊
Key Findings & Data:Methods: The study group consisted of 131 consecutive hypertensive patients without any complaint of angina pectoris or congestive heart failure.
💡
Conclusion & Impact:Silent ischemia was significantly correlated with the presence of aortic valve sclerosis (r=0.27, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Silent myocardial ischemia has been observed in hypertensive patients with a prevalence of 35-45%. Recently, aortic valve sclerosis has been identified as a manifestation of atherosclerotic process. The aim of our study was to investigate the association between silent ischemia, aortic valve sclerosis, and some other echocardiographic and laboratory parameters in a group of asymptomatic hypertensive individuals. Methods: The study group consisted of 131 consecutive hypertensive patients without any complaint of angina pectoris or congestive heart failure. Presence of silent ischemia was detected with Tl 201 myocardial perfusion scintigraphy. In echocardiographic examination left ventricular geometry, systolic and diastolic function and valvular involvement were assessed. Severity of aortic valve sclerosis was graded between 0 to 3 degrees. Results: Silent ischemia was detected in 46 patients (35%). They were significantly older, had a higher frequency of male gender and higher lipoprotein (a) levels than patients without ischemia (age: 61 ±9 years vs. 56±9 years; male gender: 57% vs. 35%, p=0.02; lipoprotein (a): 53±43 mg/dl vs. 36±32 mg/dl, p=0.01). Left ventricular mass, systolic and diastolic function did not differ between both groups. Silent ischemia was significantly correlated with the presence of aortic valve sclerosis (r=0.27, p

Özet

Amaç: Hipertansiyonda sessiz miyokard iskemisi görülme oranı %35-40'dır. Son zamanlarda aort kapak sklerozu aterosklerotik sürecin bir göstergesi olarak kabul edilmektedir. Bu çalışmanın amacı, asemptomatik hipertansif bireylerde sessiz iskemi, aort kapak sklerozu ve bazı ekokardiyografik ve biyokimyasal parametreler arasındaki ilişkiyi incelemektir. Metod: Çalışmaya angina pektoris veya konjestif kalp yetersizliği semptomları olmayan 131 ardışık hipertansif hasta alındı. Sessiz iskemi varlığı Talyum-201 miyokard perfüzyon sintigrafisi ile araştırıldı. Ekokardiyagrafi ile sol ventrikül geometrisi, sistolik ve diyastolik fonksiyonlar ve aort kapak yapısı değerlendirildi. Aort kapak sklerozu sklerozun şiddetine göre 0-3 arasında derecelendirildi. Bulgular: Sessiz iskemi 46 hastada (%35) saptandı. Sessiz iskemi saptanan grupta erkek cinsiyet oranı, yaş ortalamaları ve lipoprotein(a) seviyeleri sessiz iskemi saptanmayan gruptan daha yüksekti (erkek cinsiyet: %57 karşı %35, yaş: 61 ± 9 yıl karşı 56±9 yıl, lipoprotein(a): 53±43 mg/dl karşı 36±32 mg/dl, p=0.0l). Sol ventrikül kitlesi, sistolik ve diyastolik fonksiyonlar her iki grupta da benzerdi. Sessiz iskemi aort kapak sklerozu ile anlamlı derecede ilişkiliydi( r= 0,27, p

🔖

Cite This Article

KAHRAMAN, G., DEMİR, H., ŞAHİN, T., URAL, D., AKTOLUN, C., ÖZDEN, M., BERK, F., VURAL, A., AĞAÇDİKEN, A., URAL, E., KOMSUOĞLU, B. (2022). Relationship between silent myocardial ischemia and aortic valve sclerosis in patients with essantial hypertansion. Türk Kardiyoloji Derneği Arşivi, Cilt: 31 - Sayı: 1, 29–34. https://ajindex.com/articles/633883

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Krittayaphong R, Sheps DS: Relation between blood pressure at rest and perception of angina pectoris during exercise testing. Am J Cardiol 1996
  2. 6 2. Kannel WB, Dannenberg AL, Abbott RD: Unrecognized myocardial infarction and hypertension: the Framingham Study. Am Heart J 1985
  3. 5 3. Kannel WB: Framingham Study insights into hypertensive risk of cardiovascular disease. Hypertens Res 1995
  4. 96 4. Laukkanen JA, Kurl S, Lakka TA, Tuomainen TP, Rauramaa R, Salonen R, et al: Exercise-induced sileni myocardial ischemia and coronary morbidity and mortality in middle-aged men. J Am Coll Cardiol 2001
  5. 9 5. Szlachcic J, Tubau JF, O'Kelly B, Amnion S, Massie BM: Influence of therapy on silent ischemia and ventricular arrhythmias in hypertensive patients. J Cardiovasc Pharmacol 1991
  6. S106-8 6. Pancholy SB, Schalet B, Kuhlmeier V, Cave V, Heo J, Iskandrian AS:Prognostic significance of silent ischemia. J Nucl Cardiol 1994
  7. 40 7. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, et al: Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol 1997
  8. 4 8. Aronow WS, Ahn C, Shirani J, Kronzon I: Comparison of frequency of new coronary events in older subjects with and without valvular aortic sclerosis. Am J Cardiol 1999
  9. 600 9. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS: Association of aortic valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999
  10. 7 10. Agmon Y, Khandheria BK, Meissner I, Sicks JRD, O'Fallon WM, Wiebers DO, et al: Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease? J Am Coll Cardiol 2001
  11. 34 11. Carabeilo BA: Aortic sclerosis: a window to the coronary arteries? N Engl J Med 1999
  12. 5 12. Sahn DJ, DeMaria A, Kisslo J, Weyman A: Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978
  13. 83 13. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977
  14. 8 14. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP: Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987
  15. 60 15. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relation of left ventricular mass and geometry to morbidity and mo